Conmed (Conmed) COGS-to-Revenue : 0.44 (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Conmed COGS-to-Revenue?

Conmed's Cost of Goods Sold for the three months ended in Dec. 2023 was $145 Mil. Its Revenue for the three months ended in Dec. 2023 was $327 Mil.

Conmed's COGS to Revenue for the three months ended in Dec. 2023 was 0.44.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Conmed's Gross Margin % for the three months ended in Dec. 2023 was 55.70%.

Conmed COGS-to-Revenue Historical Data

The historical data trend for Conmed's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed COGS-to-Revenue Chart

Conmed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.45

0.47

0.44

0.45

0.46

Conmed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.47	0.47	0.46	0.45	0.44

Conmed COGS-to-Revenue Calculation

Conmed's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	568.499	/	1244.744
	=	0.46

Conmed's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	144.87	/	327.045
	=	0.44

Conmed (NYSE:CNMD) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Conmed's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	144.87 / 327.045
	=	55.70 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Conmed COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Conmed's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Conmed (Conmed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (NYSE:CNMD) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

EC8:Germany

Address

11311 Concept Boulevard, Largo, FL, USA, 33773

Website

https://www.conmed.com

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Executives

Peters Stanley W Iii	officer: VP GM General Surgery	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Todd W. Garner	officer: Executive Vice President & CFO	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Edward A. Clifford	officer: VP Global Manufacturing	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Curt R Hartman	director	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John D. Ferrell	officer: Executive Vice President - HR	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Brian Concannon	director	HAEMONETICS CORP, 400 WOOD RD, BRAINTREE MA 02184-9144
Peter K Shagory	officer: EVP,STRAT & CORP DEVT	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Daniel Jonas	officer: Vice President/Legal Affairs, other: General Counsel	C/O CONMED CORP, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Terence M Berge	officer: VP Corp. Treasurer	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Johonna Marie Pelletier	officer: Treasurer and VP, Tax	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Jerome J. Lande	director	1 WORLD TRADE CENTER, 85TH FLOOR, NEW YORK NY 10007
Brent Lalomia	officer: Vice President QA and RA	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
John Jed Kennedy	officer: VP GM GI	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773
Mark E Tryniski	director	C/O CONMED CORP., 11311 CONCEPT BOULEVARD, LARGO FL 33773
Pat Beyer	officer: President-Conmed International	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO FL 33773